Today: 28 November 2025
Subscribe
Browse Tag

Kenvue

Kenvue (KVUE) Stock Today: Dividend Payout, Insider Buying and Kimberly-Clark Deal in Focus – November 26, 2025

Kenvue (KVUE) Stock Today: Dividend Payout, Insider Buying and Kimberly-Clark Deal in Focus – November 26, 2025

Kenvue Inc. (NYSE: KVUE) — the Johnson & Johnson consumer-health spin‑off behind Tylenol, Listerine and Neutrogena — is back in the spotlight on Wednesday, November 26, 2025, as the stock trades higher on dividend payday, fresh insider and hedge‑fund buying
26 November 2025
 ·  ·  ·  ·  ·  · 
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven care en.wikipedia.org. As a spin-off,
4 November 2025
 ·  ·  ·  ·  ·  ·  · 
Go toTop